   
  
IP/N/1/CAN/21  
IP/N/1/CAN/P/14  
 
8 April 2019  
(19-2220)  Page: 1/2 
Council for Trade -Related Aspects  of 
Intellectual Property Rights  Original: English/French  
 
NOTIFICATION OF LAWS  AND REGULATIONS  
UNDER ARTICLE 63.2 O F THE TRIPS AGREEMENT  
CANADA : CANADIAN PATENT ACT  
Notifying Member  CANADA  
 
Details of the notified legal text  
 
Title Canadian Patent Act  
Subject matter  Patents (including plant variety protection)  
Nature of 
notification  [X] Main dedicated intellectual property law or regulation  
[  ] Other law or regulation  
Link to legal text  https://members.wto.org/crnattachments/2018/IP/CAN/18_2976_00_e.pdf  
Notification status  [  ] First notification  
[  ] Amendment or revision to notified legal text  
[X] Replacement or consolidation of notified legal text(s)  
Previous 
notification(s) 
referred  to IP/N/1/CAN/18, IP/N/1/CAN/P/13  
Brief description of the notified legal tex t 
 
Canadian Patent Act, as amended by Bill C -30, An Act to implement the Comprehensive Economic 
and Trade Agreement between Canada and the European Union and its Member States and to 
provide for certain other measures.  
 
Bill C-30 amends the Patent Act, under new sections 104 to 134, to make available a Certificate of 
Supplementary Protection (CSP) for eligible new medicinal ingredients or new combinations of 
medicinal ingredients that are contained in human and veterinary drugs, following expiry of an 
eligible patent. The rights of a CSP match those of the patent as they apply to a medicinal ingredient 
or combination in a drug, with a few exceptions.  
 
Bill C-30 also amends section 55.2(4) of the Patent Act to allow the Governor in Council to make 
regulati ons that will ensure that disputes brought under the Patented Medicines (Notice of 
Compliance) Regulations, which constitute Canada' s pharmaceutical patent linkage regime, provides 
litigants with an equivalent and effective right of appeal.  
 
(See also "Other information " below)  
Language(s) of 
notified legal text English, French  IP/N/1/CAN/21 • IP/N/1/CAN/P/14  
 
- 2 - 
 
  Entry into force  21 September 2017; Bill C -30 received Royal Assent on 16 May 2017, and 
entered into force on 21 September 2017.  
Other date   Adoption : 16 May 2017  
 
Notification details  
 
Submission date 
of notification  25 May 2018  
Other information  Bill C-30 amends the Patent Act  
 
Bill C-30: http://www.parl.ca/DocumentViewer/en/42 -1/bill/C -30/royal -
assent  
 
Patent Act (as amended) : http://laws -lois.justice.gc.ca/eng/acts/P -
4/FullText.html  
 
Agency or 
authority 
responsibl e Innovation, Science and Economic Development  
Patent Policy Directorate  
  
235 Queen Street  
Ottawa, Ontario K1A 0H5  
Canada  
Telephone:    343 -291-2686 
 